← Leaderboards
Barbara Burtness
Yale University
$2,957,738
Attributed
$2,957,738
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,725,158 · 6
By mechanism
P50$14,546,635 · 5
P30$178,523 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Karen S Anderson$26,797,421
- Ira M Hall$31,719,300
- Edward Chu$17,954,928
- Craig M Crews$33,790,660
Others in their field
Other Emerging Leaders on “Head And Neck Cancer”
- Greg Yothers · University Of Chicago$35,003,821
- Sana D Karam · University Of Colorado Denver$9,006,673
- J. Silvio Gutkind · University Of California, San Diego$7,159,331
- Clifton David Fuller · University Of Illinois At Chicago$6,324,911
- Evan Michael Graboyes · Medical University Of South Carolina$5,707,491
- Zachary Scott Morris · University Of Wisconsin-Madison$5,340,608
Research focus
Head And Neck CancerTherapy ResistantGenerationsResistanceMalignant NeoplasmsClinical TrialsTumorTp53 GeneResearch PersonnelMutationHead And Neck StructureFutureDna DamageTranslational ResearchClinicClinical ResearchBasic ScienceHead And Neck Squamous Cell CarcinomaHpv-Negative Head And Neck CancerAurora Kinase AProgramsFundingResourcesYale Cancer Center
Grant awards (22)
Developmental Therapeutics Research Program$97,006
P30 · FY2025 · CA · contact PI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer$2,179,298
P50 · FY2024 · DE · contact PI
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer$475,286
P50 · FY2024 · DE · contact PI
Administrative Core$193,997
P50 · FY2024 · DE · contact PI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer$96,972
P50 · FY2024 · DE · contact PI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer$89,092
P50 · FY2024 · DE · contact PI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer$87,961
P50 · FY2024 · DE · contact PI
Developmental Therapeutics Research Program$81,517
P30 · FY2024 · CA · contact PI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer$2,225,217
P50 · FY2023 · DE · contact PI
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer$480,846
P50 · FY2023 · DE · contact PI
Administrative Core$202,740
P50 · FY2023 · DE · contact PI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer$98,338
P50 · FY2023 · DE · contact PI
Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer$74,139
P50 · FY2023 · DE · contact PI
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer$74,139
P50 · FY2023 · DE · contact PI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer$2,219,566
P50 · FY2022 · DE · contact PI
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer$506,448
P50 · FY2022 · DE · contact PI
Administrative Core$159,618
P50 · FY2022 · DE · contact PI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer$85,665
P50 · FY2022 · DE · contact PI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer$2,256,456
P50 · FY2021 · DE · contact PI
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer$512,829
P50 · FY2021 · DE · contact PI
Administrative Core$173,312
P50 · FY2021 · DE · contact PI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer$2,354,716
P50 · FY2020 · DE · contact PI